Cite
HARVARD Citation
Tagawa, S. et al. (2021). TROPHY-U-01: A Phase II Open-Label Study of Sacituzumab Govitecan in Patients With Metastatic Urothelial Carcinoma Progressing After Platinum-Based Chemotherapy and Checkpoint Inhibitors. Journal of clinical oncology. 39 (22), pp. 2474-2485. [Online].